Characterizing the Effect of Cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 Genetic Polymorphisms on Stereoselective N‐demethylation of Fluoxetine. Issue 3 (24th January 2014)
- Record Type:
- Journal Article
- Title:
- Characterizing the Effect of Cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 Genetic Polymorphisms on Stereoselective N‐demethylation of Fluoxetine. Issue 3 (24th January 2014)
- Main Title:
- Characterizing the Effect of Cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 Genetic Polymorphisms on Stereoselective N‐demethylation of Fluoxetine
- Authors:
- Wang, Zhangting
Wang, Shengjia
Huang, Minmin
Hu, Haihong
Yu, Lushan
Zeng, Su - Abstract:
- <abstract abstract-type="main"> <title>ABSTRACT</title> <p>Fluoxetine (FLX) is one of the most widely prescribed selective serotonin reuptake inhibitors. Although FLX is used as racemate in the clinic, the <named-content content-type="chemicalTechnology" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">clinical pharmacokinetics</named-content> of FLX and its N‐demethylation metabolite norfluoxetine (NFLX) show obvious cytochrome P450 (CYP) polymorphism dependency and exhibit marked stereoselectivity. However, the kinetic profiles of CYP variants to FLX remain unclear. In the present study, some variants of human CYP2C8, CYP2C9, and CYP2D6 were first expressed in insect cells, and their catalytic roles with respect to FLX enantiomers were then investigated. CYP2C8.4 and CYP2C9.10 showed significantly lower activity and CYP2C8.3 showed significantly higher activity toward both <italic>R</italic>‐ and <italic>S</italic>‐FLX compared with the wildtype, while CYP2C9.3, CYP2C9.13, and CYP2C9.16 showed significantly lower activity only toward <italic>R</italic>‐FLX. Five CYP2C9 variants and CYP2D6.1 exhibited significantly <named-content content-type="reactionType" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">stereoselective</named-content> kinetic profiles prior to <italic>R</italic>‐FLX, and CYP2C8.3 showed a slight stereoselectivity. Interestingly, obvious substrate inhibition was observed in the CYP2C9 wildtype and its three variants only in the<abstract abstract-type="main"> <title>ABSTRACT</title> <p>Fluoxetine (FLX) is one of the most widely prescribed selective serotonin reuptake inhibitors. Although FLX is used as racemate in the clinic, the <named-content content-type="chemicalTechnology" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">clinical pharmacokinetics</named-content> of FLX and its N‐demethylation metabolite norfluoxetine (NFLX) show obvious cytochrome P450 (CYP) polymorphism dependency and exhibit marked stereoselectivity. However, the kinetic profiles of CYP variants to FLX remain unclear. In the present study, some variants of human CYP2C8, CYP2C9, and CYP2D6 were first expressed in insect cells, and their catalytic roles with respect to FLX enantiomers were then investigated. CYP2C8.4 and CYP2C9.10 showed significantly lower activity and CYP2C8.3 showed significantly higher activity toward both <italic>R</italic>‐ and <italic>S</italic>‐FLX compared with the wildtype, while CYP2C9.3, CYP2C9.13, and CYP2C9.16 showed significantly lower activity only toward <italic>R</italic>‐FLX. Five CYP2C9 variants and CYP2D6.1 exhibited significantly <named-content content-type="reactionType" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">stereoselective</named-content> kinetic profiles prior to <italic>R</italic>‐FLX, and CYP2C8.3 showed a slight stereoselectivity. Interestingly, obvious substrate inhibition was observed in the CYP2C9 wildtype and its three variants only in the case of <italic>R</italic>‐FLX. Together, these findings suggest that CYP2C9 and CYP2D6 polymorphism may play an important role in the clearance of FLX and also in the <named-content content-type="reactionType" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">stereoselective</named-content> kinetic profiles of FLX enantiomers. <italic>Chirality 26:166–173, 2014</italic>. © 2014 Wiley Periodicals, Inc.</p> </abstract> … (more)
- Is Part Of:
- Chirality. Volume 26:Issue 3(2014:Mar.)
- Journal:
- Chirality
- Issue:
- Volume 26:Issue 3(2014:Mar.)
- Issue Display:
- Volume 26, Issue 3 (2014)
- Year:
- 2014
- Volume:
- 26
- Issue:
- 3
- Issue Sort Value:
- 2014-0026-0003-0000
- Page Start:
- 166
- Page End:
- 173
- Publication Date:
- 2014-01-24
- Subjects:
- Chirality -- Periodicals
Pharmaceutical chemistry -- Periodicals
541.22 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1520-636X ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/chir.22289 ↗
- Languages:
- English
- ISSNs:
- 0899-0042
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3181.124450
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3428.xml